Reply to 'Comment on 'Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy''.
Loading...
ICR Authors
Authors
Bowyer, S
Prithviraj, P
Lorigan, P
Larkin, J
McArthur, G
Atkinson, V
Millward, M
Khou, M
Diem, S
Ramanujam, S
Kong, B
Liniker, E
Guminski, A
Parente, P
Andrews, MC
Parakh, S
Cebon, J
Long, GV
Carlino, MS
Klein, O
Prithviraj, P
Lorigan, P
Larkin, J
McArthur, G
Atkinson, V
Millward, M
Khou, M
Diem, S
Ramanujam, S
Kong, B
Liniker, E
Guminski, A
Parente, P
Andrews, MC
Parakh, S
Cebon, J
Long, GV
Carlino, MS
Klein, O
Document Type
Journal Article
Date
2017-04
Date Accepted
Date Available
Abstract
Citation
British journal of cancer, 2017, 116 (8), pp. e15 - ?
Source Title
Publisher
ISSN
0007-0920
eISSN
1532-1827
Collections
Research Team
Melanoma and Kidney Cancer